INDV
Indivior Pharmaceuticals, Inc.
Nasdaq Pharmaceutical Preparations Large accelerated filer

Key Financials

Gross Profit
$994.0M
↑ 3.9%
Net Income
$210.0M
↑ 10400.0%
Revenue
$1.2B
↑ 4.3%
Operating Income
$262.0M
↑ 718.8%
Total Assets
$1.2B
↓ 8.9%
Total Liabilities
$1.3B
↓ 22.1%
Cash & Equivalents
$195.0M
↓ 38.9%
EPS (Diluted)
$1.64
↑ 8100.0%

Recent SEC Filings

Form Type Filed Date Link
SCHEDULE 13G 9/30/2026 View on SEC
425 9/17/2026 View on SEC
8-K 9/17/2026 View on SEC
8-K 9/15/2026 View on SEC
EFFECT 9/11/2026 View on SEC
424B3 9/11/2026 View on SEC
S-4/A 9/9/2026 View on SEC
S-4 8/28/2026 View on SEC
4 8/27/2026 View on SEC
SCHEDULE 13D/A 8/13/2026 View on SEC

Company Information

Field Value
Ticker INDV
Company Name Indivior Pharmaceuticals, Inc.
CIK 1625297
Sector Pharmaceutical Preparations
Industry Large accelerated filer
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 804-379-1090